Grossinger Neuropain Spclst Wilmington, DE - 19804

Grossinger Neuropain Spclst is categorized under Pathologists in Wilmington, DE and active since 2010.

Grossinger Neuropain Spclst was established in 2010, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Pathologists business, which does work in the B2C market, and is classified as a Pathologists, under code number 6214930 by the NAICS.

If you are seeking more information, feel free to contact Blanche Donato, Manager at the company’s single location by writing to 4100 Dawnbrook Drive # 4, Wilmington, Delaware DE 19804 or by phoning (302) 636-0920. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Grossinger Neuropain Spclst
Contact Person: Blanche Donato, Manager
Address: 4100 Dawnbrook Drive # 4, Wilmington, Delaware 19804
Phone Number: (302) 636-0920
Website Address: drgrossinger.com
Annual Revenue (USD): $1.000.000 to $2.499.999
Founded: 2010
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Pathologists
SIC Code: 8011
NAICS Code: 6214930
Share This Business:

Grossinger Neuropain Spclst was started in 2010 to provide professional Pathologists under the SIC code 8011 and NAICS code 6214930. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.

Feel free to contact Blanche Donato, Manager for inquiries that concern Grossinger Neuropain Spclst by calling the company number (302) 636-0920, as your correspondence is most welcome. Additionally, the physical location of the single location of Grossinger Neuropain Spclst can be found at the coordinates 39.712,-75.64572 as well as the street address 4100 Dawnbrook Drive # 4 in Wilmington, Delaware 19804.

For its online presence, you may visit Grossinger Neuropain Spclst’s website at drgrossinger.com and engage with its social media outlets through on Twitter and on Facebook.